Drug Type Small molecule drug |
Synonyms Teglarinad, Teglarinad chloride (USAN/INN) + [2] |
Target |
Mechanism NAMPT inhibitors(Nicotinamide phosphoribosyltransferase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H43Cl2N5O8 |
InChIKeyDAHMXVAETAAQOZ-UHFFFAOYSA-N |
CAS Registry432037-57-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09678 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 2 | US | 01 Jun 2008 | |
Lymphoma | Phase 2 | - | - | |
Lymphoma | Phase 2 | US | - | |
Lymphoma | Phase 2 | - | - | |
Lymphoma | Phase 2 | - | - | |
Lymphoma | Phase 2 | - | - | |
Solid tumor | Phase 2 | US | - | |
Solid tumor | Phase 2 | US | - | |
Lymphoma | Phase 1 | US | - |